Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.

Tan CK, Carey AJ, Cui X, Webb RI, Ipe D, Crowley M, Cripps AW, Benjamin WH Jr, Ulett KB, Schembri MA, Ulett GC.

Infect Immun. 2012 Sep;80(9):3145-60. doi: 10.1128/IAI.00023-12. Epub 2012 Jun 25.

2.

Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.

Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL.

Infect Immun. 2012 Dec;80(12):4186-94. doi: 10.1128/IAI.00684-12. Epub 2012 Sep 17.

3.

Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection.

Duell BL, Carey AJ, Tan CK, Cui X, Webb RI, Totsika M, Schembri MA, Derrington P, Irving-Rodgers H, Brooks AJ, Cripps AW, Crowley M, Ulett GC.

J Immunol. 2012 Jan 15;188(2):781-92. doi: 10.4049/jimmunol.1101231. Epub 2011 Dec 19.

4.

Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection.

Kline KA, Schwartz DJ, Lewis WG, Hultgren SJ, Lewis AL.

Infect Immun. 2011 Sep;79(9):3588-95. doi: 10.1128/IAI.00122-11. Epub 2011 Jun 20.

5.

Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.

Walters MS, Lane MC, Vigil PD, Smith SN, Walk ST, Mobley HL.

MBio. 2012 Feb 7;3(1). pii: e00303-11. doi: 10.1128/mBio.00303-11. Print 2012.

6.

Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1alpha.

Ulett GC, Webb RI, Ulett KB, Cui X, Benjamin WH, Crowley M, Schembri MA.

J Infect Dis. 2010 Mar 15;201(6):866-70. doi: 10.1086/650696.

PMID:
20132033
7.

Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.

Danka ES, Hunstad DA.

J Infect Dis. 2015 Apr 1;211(7):1164-73. doi: 10.1093/infdis/jiu577. Epub 2014 Oct 21.

8.

Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection.

Carey AJ, Sullivan MJ, Duell BL, Crossman DK, Chattopadhyay D, Brooks AJ, Tan CK, Crowley M, Sweet MJ, Schembri MA, Ulett GC.

J Infect Dis. 2016 Feb 15;213(4):659-68. doi: 10.1093/infdis/jiv424. Epub 2015 Aug 30.

PMID:
26324782
9.

Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.

Hannan TJ, Mysorekar IU, Hung CS, Isaacson-Schmid ML, Hultgren SJ.

PLoS Pathog. 2010 Aug 12;6(8):e1001042. doi: 10.1371/journal.ppat.1001042.

10.

Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.

Hopkins WJ, Gendron-Fitzpatrick A, Balish E, Uehling DT.

Infect Immun. 1998 Jun;66(6):2798-802.

11.
12.

Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection.

Spencer JD, Jackson AR, Li B, Ching CB, Vonau M, Easterling RS, Schwaderer AL, McHugh KM, Becknell B.

PLoS One. 2015 Dec 10;10(12):e0144024. doi: 10.1371/journal.pone.0144024. eCollection 2015.

13.

Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.

Billips BK, Forrestal SG, Rycyk MT, Johnson JR, Klumpp DJ, Schaeffer AJ.

Infect Immun. 2007 Nov;75(11):5353-60. Epub 2007 Aug 27.

14.

Escherichia coli global gene expression in urine from women with urinary tract infection.

Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HL.

PLoS Pathog. 2010 Nov 11;6(11):e1001187. doi: 10.1371/journal.ppat.1001187.

15.

Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.

Lin AE, Beasley FC, Olson J, Keller N, Shalwitz RA, Hannan TJ, Hultgren SJ, Nizet V.

PLoS Pathog. 2015 Apr 30;11(4):e1004818. doi: 10.1371/journal.ppat.1004818. eCollection 2015 Apr.

16.

Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.

Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8829-35. Review.

17.

Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.

Bokil NJ, Totsika M, Carey AJ, Stacey KJ, Hancock V, Saunders BM, Ravasi T, Ulett GC, Schembri MA, Sweet MJ.

Immunobiology. 2011 Nov;216(11):1164-71. doi: 10.1016/j.imbio.2011.05.011. Epub 2011 May 24.

PMID:
21802164
18.

β-Hemolysin/cytolysin of Group B Streptococcus enhances host inflammation but is dispensable for establishment of urinary tract infection.

Kulkarni R, Randis TM, Antala S, Wang A, Amaral FE, Ratner AJ.

PLoS One. 2013;8(3):e59091. doi: 10.1371/journal.pone.0059091. Epub 2013 Mar 7.

19.

YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration.

Lau ME, Loughman JA, Hunstad DA.

Infect Immun. 2012 Dec;80(12):4123-32. doi: 10.1128/IAI.00801-12. Epub 2012 Sep 10.

20.

The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection.

Sivick KE, Schaller MA, Smith SN, Mobley HL.

J Immunol. 2010 Feb 15;184(4):2065-75. doi: 10.4049/jimmunol.0902386. Epub 2010 Jan 18.

Supplemental Content

Support Center